A new diagnostic and treatment strategy provided an 80% reduction in the one-year recurrence rate and a 92% reduction of total burden of syncope in some forms of neurally-mediated syncope. This ...
CHICAGO -- A select number of patients who suffer from neurally mediated synope (NMS) – a disorder in which the brain fails to regulate heart rate and blood pressure – may be good candidates to ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2021" report to their offering. "United Kingdom ...